Sanofi (SNY) Major Shareholders

Executive TeamFinancialsShareholders

Sanofi shareholders at a glance

The largest holder of Sanofi stock is L'OréAl, with 88.7 million shares (7.34% of the company) as of September 25, 2026. The 10 largest holders together own 9.5%.

In Q2 2026, 746 institutional holdings reports listed 190.0 million shares worth $8.09 billion, down 9.5% in shares from Q1 2026.

Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026).

SNY logo

Sanofi

SNYFrance
Healthcare

Shareholders Summary

2026Q2

Filings
746
Options Value
$176.00M
Value (excl. Options)
$8.09B
Shares (excl. Options)
190.00M

Ownership by Type

Geographic Distribution

Largest Sanofi shareholders

HolderShares% of companyValue
L'OréAl88.7 million7.34%–
Sanofi12.0 million0.99%–
OFI Invest Asset Management SA3.4 million0.28%–
Goldman Sachs Asset Management International2.3 million0.19%–
Sjunde Ap Fonden (Investment Management)1.6 million0.14%–
Goldman Sachs Asset Management BV1.6 million0.13%–
Nordea Investment Management AB (Norway)1.6 million0.13%–
State Street Global Advisors Europe Ltd.1.5 million0.12%–
Pacer Advisors, Inc.1.2 million0.10%–
State Street Global Advisors Ltd.1.1 million0.09%–

As of September 25, 2026.

Sanofi institutional holdings by quarter

QuarterReportsSharesValue
Q2 2026746190.0 million$8.1B
Q1 2026768210.0 million$10.1B
Q4 2025787223.0 million$10.8B
Q3 2025748241.0 million$11.4B
Q2 2025759248.0 million$12.0B
Q1 2025804260.0 million$14.4B
Q4 2024758264.0 million$12.8B
Q3 2024788284.0 million$16.4B

Shares and value held by institutions that file quarterly holdings reports (options not included).

Questions and answers

Who owns the most Sanofi stock?

L'OréAl, with 7.34% of the company (as of September 25, 2026). Next: Sanofi (0.99%) and OFI Invest Asset Management SA (0.28%).

How many institutions own Sanofi stock?

746 institutional holdings reports listed Sanofi shares in Q2 2026, 190.0 million shares in all worth $8.09 billion.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube